Sinopharm Group Co's total assets for Q4 2025 were ¥390.53B, a decrease of -7.05% from the previous quarter. SHTDF total liabilities were ¥256.31B for the fiscal quarter, a -11.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.